Related Experiment Video
Updated: May 21, 2026

Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
Published on: July 14, 2023
Commentary: Protecting human subjects and their data in multi-site research
1Palo Alto Medical Foundation Research Institute, Palo Alto, CA 94301, USA. lufth@pamfri.org
Using real-world data for comparative effectiveness research requires careful data authorization, Institutional Review Board (IRB) navigation, and robust privacy protection strategies to maintain data utility while minimizing patient identity risks.
Area of Science:
- Health Services Research
- Data Privacy
- Clinical Research Ethics
Background:
- Comparative effectiveness research (CER) increasingly utilizes routinely collected real-world data (RWD).
- RWD offers valuable insights but presents challenges in data access, multi-site Institutional Review Board (IRB) oversight, and data security.
- Balancing research needs with patient privacy is crucial for ethical RWD utilization.
Purpose of the Study:
- To address the complexities of using RWD for CER.
- To outline strategies for navigating data authorization, IRB approvals, and data protection.
- To discuss methods for minimizing patient identity disclosure risks in RWD research.
Main Methods:
- Review of challenges in RWD utilization for CER.
- Discussion of strategies for data governance and ethical review processes.
- Exploration of data de-identification techniques and risk mitigation.
Main Results:
- Distinguishing quality improvement from research aids IRB reviews for low-risk studies.
- Complete data de-identification significantly reduces research value.
- Creative data protection strategies can substantially lower the risk of inadvertent patient identity disclosure.
Conclusions:
- Effective CER using RWD necessitates proactive management of ethical and logistical hurdles.
- Strategic data handling balances the need for detailed RWD with stringent patient privacy requirements.
- Implementing robust data security and privacy protocols is essential for responsible RWD research.
Related Concept Videos
Ethics in Research
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Naturalistic Observations
Legal Guidelines for Documentation

